-
2
-
-
79955571240
-
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study
-
Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011;377: 1495-505.
-
(2011)
Lancet
, vol.377
, pp. 1495-1505
-
-
Boehme, C.C.1
Nicol, M.P.2
Nabeta, P.3
-
3
-
-
79953101714
-
Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009
-
Cui Z, Wang J, Lu J, Huang X, Hu Z. Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009. BMC Infect Dis 2011; 11:78.
-
(2011)
BMC Infect Dis
, vol.11
, pp. 78
-
-
Cui, Z.1
Wang, J.2
Lu, J.3
Huang, X.4
Hu, Z.5
-
4
-
-
33746899375
-
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis
-
Hazbón MH, Brimacombe M, Boba-dilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006;50:2640-9.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 2640-2649
-
-
Hazbón, M.H.1
Brimacombe, M.2
Boba-Dilla Del Valle, M.3
-
5
-
-
33845583280
-
Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing
-
Shi R, Zhang J, Li C, Kazumi Y, Suga-wara I. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J Clin Microbiol 2006;44: 4566-8.
-
(2006)
J Clin Microbiol
, vol.44
, pp. 4566-4568
-
-
Shi, R.1
Zhang, J.2
Li, C.3
Kazumi, Y.4
Suga-Wara, I.5
-
6
-
-
84923201410
-
Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin
-
Singh P, Jain A, Dixit P, et al. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin. J Antibiot (Tokyo) 2015;68:63-6.
-
(2015)
J Antibiot (Tokyo)
, vol.68
, pp. 63-66
-
-
Singh, P.1
Jain, A.2
Dixit, P.3
-
7
-
-
34447542068
-
Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: Associated genetic mutations and relationship to antimicrobial exposure
-
Wang JY, Lee LN, Lai HC, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J Antimicrob Chemother 2007;59:860-5.
-
(2007)
J Antimicrob Chemother
, vol.59
, pp. 860-865
-
-
Wang, J.Y.1
Lee, L.N.2
Lai, H.C.3
-
8
-
-
84859054656
-
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: A systematic review
-
Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 2012;7(3):e33275.
-
(2012)
Plos One
, vol.7
, Issue.3
, pp. e33275
-
-
Georghiou, S.B.1
Magana, M.2
Garfein, R.S.3
Catanzaro, D.G.4
Catanzaro, A.5
Rodwell, T.C.6
-
9
-
-
23044445646
-
Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis
-
Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005;49: 3192-7.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 3192-3197
-
-
Maus, C.E.1
Plikaytis, B.B.2
Shinnick, T.M.3
-
10
-
-
84885009252
-
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance
-
Zhang H, Li D, Zhao L, et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 2013;45: 1255-60.
-
(2013)
Nat Genet
, vol.45
, pp. 1255-1260
-
-
Zhang, H.1
Li, D.2
Zhao, L.3
-
11
-
-
85008311676
-
Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use
-
Chakravorty S, Roh SS, Glass J, et al. Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use. J Clin Microbiol 2016;55:183-98.
-
(2016)
J Clin Microbiol
, vol.55
, pp. 183-198
-
-
Chakravorty, S.1
Roh, S.S.2
Glass, J.3
-
12
-
-
85029576976
-
-
Sunnyvale CA Cepheid February package insert
-
Xpert MTB/RIF. Sunnyvale, CA: Cepheid, February 2015 (package insert).
-
(2015)
Xpert MTB/RIF
-
-
-
13
-
-
0034084624
-
The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis
-
Slayden RA, Barry CE III. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Microbes Infect 2000;2:659-69.
-
(2000)
Microbes Infect
, vol.2
, pp. 659-669
-
-
Slayden, R.A.1
Barry, C.E.2
-
14
-
-
0029909110
-
Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis
-
Xu C, Kreiswirth BN, Sreevatsan S, Musser JM, Drlica K. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J Infect Dis 1996;174:1127-30.
-
(1996)
J Infect Dis
, vol.174
, pp. 1127-1130
-
-
Xu, C.1
Kreiswirth, B.N.2
Sreevatsan, S.3
Musser, J.M.4
Drlica, K.5
-
15
-
-
0028299121
-
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations
-
Takiff HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994;38:773-80.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 773-780
-
-
Takiff, H.E.1
Salazar, L.2
Guerrero, C.3
-
16
-
-
84924968523
-
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay
-
Kambli P, Ajbani K, Sadani M, et al. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay. Tuberculosis (Edinb) 2015;95:137-41.
-
(2015)
Tuberculosis (Edinb)
, vol.95
, pp. 137-141
-
-
Kambli, P.1
Ajbani, K.2
Sadani, M.3
-
17
-
-
0031958711
-
Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene
-
Suzuki Y, Katsukawa C, Tamaru A, et al. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 1998;36:1220-5.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 1220-1225
-
-
Suzuki, Y.1
Katsukawa, C.2
Tamaru, A.3
-
18
-
-
84959102843
-
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables
-
Kambli P, Ajbani K, Nikam C, et al. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. Int J Mycobacteriol 2016;5:1-6.
-
(2016)
Int J Mycobacteriol
, vol.5
, pp. 1-6
-
-
Kambli, P.1
Ajbani, K.2
Nikam, C.3
-
19
-
-
0032466234
-
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update
-
Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998;79:3-29.
-
(1998)
Tuber Lung Dis
, vol.79
, pp. 3-29
-
-
Ramaswamy, S.1
Musser, J.M.2
-
20
-
-
84865394422
-
The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region
-
Gikalo MB, Nosova EY, Krylova LY, Moroz AM. The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region. J Antimicrob Chemother 2012;67:2107-9.
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 2107-2109
-
-
Gikalo, M.B.1
Nosova, E.Y.2
Krylova, L.Y.3
Moroz, A.M.4
-
25
-
-
84937516929
-
Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance
-
Molina-Moya B, Lacoma A, Prat C, et al. Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance. J Infect 2015;71:220-30.
-
(2015)
J Infect
, vol.71
, pp. 220-230
-
-
Molina-Moya, B.1
Lacoma, A.2
Prat, C.3
-
26
-
-
84555220624
-
Evaluation of the GenoType MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs
-
Said HM, Kock MM, Ismail NA, et al. Evaluation of the GenoType MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2012;16:104-9.
-
(2012)
Int J Tuberc Lung Dis
, vol.16
, pp. 104-109
-
-
Said, H.M.1
Kock, M.M.2
Ismail, N.A.3
-
27
-
-
77951874370
-
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates
-
Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2010;48:1683-9.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 1683-1689
-
-
Brossier, F.1
Veziris, N.2
Aubry, A.3
Jarlier, V.4
Sougakoff, W.5
-
28
-
-
84940054531
-
Diagnostic performance of the new version (v2.0) of GenoType MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: A multicenter study
-
Tagliani E, Cabibbe AM, Miotto P, et al. Diagnostic performance of the new version (v2.0) of GenoType MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study. J Clin Microbiol 2015; 53:2961-9.
-
(2015)
J Clin Microbiol
, vol.53
, pp. 2961-2969
-
-
Tagliani, E.1
Cabibbe, A.M.2
Miotto, P.3
-
29
-
-
66749110456
-
Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens
-
Hillemann D, Rüsch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2009;47:1767-72.
-
(2009)
J Clin Microbiol
, vol.47
, pp. 1767-1772
-
-
Hillemann, D.1
Rüsch-Gerdes, S.2
Richter, E.3
-
30
-
-
84957587722
-
The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
-
Tomasicchio M, Theron G, Pietersen E, et al. The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates. Sci Rep 2016;6:17850.
-
(2016)
Sci Rep
, vol.6
, pp. 17850
-
-
Tomasicchio, M.1
Theron, G.2
Pietersen, E.3
-
31
-
-
84865694488
-
Challenging a dogma: Antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
-
Ängeby K, Juréen P, Kahlmeter G, Hoffner SE, Schön T. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. Bull World Health Organ 2012;90:693-8.
-
(2012)
Bull World Health Organ
, vol.90
, pp. 693-698
-
-
Ängeby, K.1
Juréen, P.2
Kahlmeter, G.3
Hoffner, S.E.4
Schön, T.5
-
32
-
-
84859565524
-
GyrA Mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis
-
Sirgel FA, Warren RM, Streicher EM, Victor TC, van Helden PD, Böttger EC. gyrA Mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 2012; 67:1088-93.
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 1088-1093
-
-
Sirgel, F.A.1
Warren, R.M.2
Streicher, E.M.3
Victor, T.C.4
Van Helden, P.D.5
Böttger, E.C.6
-
33
-
-
78049250845
-
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model
-
Poissy J, Aubry A, Fernandez C, et al. Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model. Antimicrob Agents Chemother 2010;54: 4765-71.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4765-4771
-
-
Poissy, J.1
Aubry, A.2
Fernandez, C.3
-
34
-
-
84959929780
-
Specific gyrA gene mutations predict poor treatment outcome in MDR-TB
-
Rigouts L, Coeck N, Gumusboga M, et al. Specific gyrA gene mutations predict poor treatment outcome in MDR-TB. J Antimicrob Chemother 2016;71:314-23.
-
(2016)
J Antimicrob Chemother
, vol.71
, pp. 314-323
-
-
Rigouts, L.1
Coeck, N.2
Gumusboga, M.3
-
35
-
-
24144469352
-
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns
-
van Rie A, Victor TC, Richardson M, et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med 2005;172:636-42.
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 636-642
-
-
Van Rie, A.1
Victor, T.C.2
Richardson, M.3
-
36
-
-
84879188574
-
Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection
-
Hingley-Wilson SM, Casey R, Connell D, et al. Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg Infect Dis 2013;19:1138-41.
-
(2013)
Emerg Infect Dis
, vol.19
, pp. 1138-1141
-
-
Hingley-Wilson, S.M.1
Casey, R.2
Connell, D.3
-
37
-
-
84970024196
-
Performance of the new version (v2.0) of the GenoType MTBDRsl test for detection of resistance to second-line drugs in multidrug-resistant Mycobacterium tuberculosis complex strains
-
Brossier F, Guindo D, Pham A, et al. Performance of the new version (v2.0) of the GenoType MTBDRsl test for detection of resistance to second-line drugs in multidrug-resistant Mycobacterium tuberculosis complex strains. J Clin Microbiol 2016; 54:1573-80.
-
(2016)
J Clin Microbiol
, vol.54
, pp. 1573-1580
-
-
Brossier, F.1
Guindo, D.2
Pham, A.3
|